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Review article 
Ανασκόπηση
ABSTRACT: Feline prostate cancer is a rare condition, which means that the literature is very sparse. This makes it 
difficult to make sound conclusions about the epidemiology and the effectiveness of the treatment strategies that are 
utilized. The literature suggests that the condition mainly affects older cats and that these tumours are usually (adeno)
carcinomas. Feline prostatic cancer patients often suffer from haematuria, dysuria and inappetence. Both surgery and 
chemotherapy have been used to treat the condition. Unfortunately, most animals still die within a year. Further re-
search is needed to better understand the epidemiology of the disease and to guide treatment decisions.
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Prostatic conditions in the cat are rare (Caney et al., 1998; Tursi et al., 2008). Prostatic abscess-
es (Mordecai et al., 2008), prostatitis (Roura et al., 
2002), paraprostatic cysts (Newell et al., 1992) and 
cancer (Hubbard et al., 1990) have all been described. 
Prostatic carcinoma has been mentioned to be the 
most common prostatic conditions in cats, but re-
mains a rare occurrence (Hubbard et al., 1990; Caney 
et al., 1998). A retrospective study investigating low-
er urinary tract tumours failed to identify any cases of 
feline prostate cancer (Sapierzyński et al., 2007).
Due to its rarity, the epidemiology and risk factors 
for feline prostatic neoplasms are poorly understood. 
Additionally, it is difficult to make the distinction 
between prostatic carcinoma and urothelial carcino-
ma that invades the prostate but originates elsewhere 
(Tursi et al., 2008).
The limited experience with the condition means 
that there are currently no standard of care or specif-
ic guidelines to guide treatment decisions (Griffin et 
al., 2018). Despite this lack of guidelines both sur-
gery and chemotherapy have been used to tackle the 
disease. 
The aim of the current paper is to synthesize the 
current literature regarding clinical aspects of feline 
prostatic carcinoma. Additionally, possible directions 
for future research and their limitations are discussed.
SEARCH STRATEGY
The PubMed, PubMed Central and Web of Sci-
ence databases were searched for database-specific 
variants and combinations of the following keywords: 
“Feline”, “Cat”, “Prostate”, “Prostatic”, “Cancer”, 
“Carcinoma” and “Adenocarcinoma”. The indices 
of Veterinary and Comparative Oncology, Journal of 
Veterinary Internal Medicine, Journal of Feline Med-
icine and Surgery and Journal of Feline Medicine and 
Surgery Open Reports were manually searched. The 
search engine Google was searched using the same 
keywords. Papers were selected if they described any 
case of feline prostate cancer, contained clinical in-
formation and had at least an English summary. Fi-
nally, the references of the selected publications were 
screened for further relevant literature.
IDENTIFIED LITERATURE
The amount of available literature regarding pros-
tatic neoplasms in cats is very limited. The identi-
fied literature consisted exclusively of case reports 
describing a maximum of two animals. The total 
number of animals included in this review was ten. 
Four further cases were identified: a case of prostatic 
fibroadenoma (Cotchin, 1984), two cases of adeno-
carcinoma and one of unknown histological subtype 
(Barsanti and Finco, 1979; Hornbuckle and Kleine, 
1980). Unfortunately, these publications were unable 
to be sourced and were therefore not included.
No case-control - studies or cohort studies assess-
ing treatment strategies or risk factors were found. 
Furthermore, no interventional studies or clinical tri-
als assessing therapeutic strategies for any type of fe-
line prostate cancer were identified.
CASE CHARACTERISTICS
The identified literature was screened for the fol-
lowing characteristics per animal: breed, age, neuter-
ing status, histological diagnosis and symptoms. The 
current review focuses on the characteristics and clin-
ical aspects of the different cases. More information 
regarding histological, diagnostic and other aspects 
can be found in the original publications.
Hawe described a ten-year old, neutered cat with 
adenocarcinoma. The breed was not specified. The an-
imal suffered for two weeks from haematuria, dysuria 
and pollakiuria (Hawe, 1983).
In 1990, Hubbard and colleagues (Hubbard et al., 
1990) described the case of an eleven-year old, neu-
tered cat that suffered from haematuria. The breed 
was not specified. The animal was diagnosed with 
prostatic adenocarcinoma.
Caney and colleagues (Caney et al., 1998) de-
scribed two cases of prostatic carcinoma in 1998. The 
first case concerned a nine-year old domestic longhair 
that was neutered. The animal suffered seven months 
from dysuria, haematuria, and increased urinary fre-
quency. Additionally, it was mentioned that there 
were two instances of urethral obstruction in the two 
months before admission. The second animal was a 
seven-year old domestic shorthair that was also neu-
tered. In addition to presenting dysuria and a single 
instance of haematuria, this animal also showed inap-
petence, weight loss, lethargy in the seven weeks be-
fore admission. Other symptoms included dyschezia 
and constipation. After exploratory surgery, this cat 
suffered from urinary incontinence and haematuria.
A case report of a nine-year old domestic shorthair 
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was published in 2004 (LeRoy and Lech, 2004). When 
the animal presented, it was suffering from diarrhoea. 
Three months later, the animal was seen again when it 
suffered from inappetence, vocalization during urina-
tion and unusually frequent licking of the perineal re-
gion. Eleven months later, the cat was suffering from 
lethargy, vomiting, weight loss, tenesmus, haematuria 
and pyuria. The animal was diagnosed with adenocar-
cinoma. 
In a case report, Tursi and colleagues (Tursi et al., 
2008) described a twelve-year old, neutered domestic 
shorthair. The cat suffered from inappetence, weight 
loss, weakness, dysuria, haematuria and dyspnoea 
and was diagnosed with prostatic adenocarcinoma.
A twelve-year old mixed-breed, neutered cat suf-
fered from dysuria, haematuria, dyschezia and con-
stipation for three weeks (Zambelli et al., 2010). The 
animal showed urinary incontinence two months after 
having surgery for his sarcomatoid carcinoma.
Lapshin and Kondratova presented a case report 
of prostatic adenocarcinoma in a cat in 2015 (Lapshin 
and Kondratova, 2015). The animal was a nine-year 
old, intact Siberian that suffered from acute urinary 
retention, stranguria, general depression, drop-by-
drop urination, anorexia and haematuria during the 
course of its disease.
In a book by Villalobos and Kaplan (Villalobos 
and Kaplan, 2017), two cases were mentioned. A thir-
teen-year old domestic short-hair suffered from pros-
tatic cancer of unknown histological type. Whether the 
animal was neutered and what its symptoms were, was 
not specified. A second cat was sixteen years old and 
was diagnosed with carcinoma. It suffered from urinary 
obstruction. Whether it was neutered, was not specified.
In the most recent case report, de Oliveira and col-
leagues (de Oliveira et al., 2019) present the case of 
a six-year old, intact domestic shorthair that was di-
agnosed with prostatic carcinoma. The cat presented 
with dysuria, haematuria, inappetence, constipation, 
lethargy and prostration. 
 Due to the small number of reports, it is difficult 
to make generalisations about the case characteristics 
to the whole population of feline prostate cancer pa-
tients. However, a few observations can be made. The 
median age of the animals diagnosed with prostate 
cancer in the reported cases was 10.5 years (range 6 
– 16 years). This supports the hypothesis that prostate 
cancer occurs mainly in older cats. It is also apparent 
from the literature that most diagnosed tumours are 
carcinomas, more specifically adenocarcinomas. Sev-
eral breeds were described, mainly domestic short-
hairs. Prostate cancer was diagnosed in both neutered 
and intact animals. Finally, several symptoms can be 
identified that are often present in cats diagnosed with 
prostate cancer. Haematuria, dysuria and inappetence 
occur often in animals suffering from the disease.
TREATMENT AND OUTCOMES
From the identified case reports, the treatment 
strategy, clinical outcome and the location of possi-
ble metastases were extracted per animal. Treatment 
for alleviating symptoms (e.g. catheterisation for re-
storing urinary outflow) and diagnostic procedures 
(e.g. retrograde contrast urethrocystogram) were per-
formed in most animals and are not specifically de-
scribed in this review.
The treatment strategy of the cat in the case report 
of Hawe (Hawe, 1983) was not specified. The animal 
was euthanized, and lung metastases were identified.
The cat in the 1990 case report (Hubbard et al., 
1990) was initially treated with a prostatectomy. Af-
terwards, doxorubicin (30mg/m²) and cyclophospha-
mide (300 mg/m²) were given. After four treatments, 
the chemotherapy was stopped due to proteinuria. The 
animal was euthanized ten months after the prostatec-
tomy due to a recurrence of the tumour. Metastasis to 
the lungs and pancreas was identified.
The nine-year old domestic longhair in the case 
report of Caney and colleagues (Caney et al., 1998) 
was treated with ampicillin (11 mg/kg daily) and beta-
methasone (0.03 mg/kg daily) for two weeks when a 
provisional diagnosis of urethritis was made. A little 
over two weeks, later, a provision transitional cell car-
cinoma diagnosis was made, and ampicillin and beta-
methasone treatment was continued. Three months 
later, the animal was euthanised due to quickly wors-
ening symptoms. No sign of metastasis to medial iliac 
lymph nodes was discovered. Microscopic metasta-
ses to the lungs where however identified. The sev-
en-year old domestic shorthair in the same case report 
(Caney et al., 1998) was treated with antibiotics and 
glucocorticoids which did not resolve the symptoms. 
A prostatic -, urethral mass or urethritis was suspected 
after retrograde positive contract urethrography. Four 
days later, the cat was euthanised due to a worsening 
of its condition. No sign of metastasis to the medial 
iliac lymph nodes or lungs was discovered.
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Three months after first presentation, the cat in 
the publication of Leroy and Lech (LeRoy and Lech, 
2004) underwent an orchiectomy. Eight months later, 
it underwent surgery again for a urethral transection 
and removal of the mass. At the same time, chemo-
therapy was initiated (enrofloxacin 15 mg daily and 
cephalexin 100 mg every 12 hours).
No treatment strategy was explicitly mentioned in 
the article of Tursi and colleagues (Tursi et al., 2008). 
The animal was euthanized when its condition deteri-
orated. The time at which this occurred was not spec-
ified. Metastasis to the lungs and myocardium was 
identified. There was also infiltration of the medias-
tinal lymph nodes.
Before being referred, the cat described by Zam-
belli and colleagues (Zambelli et al., 2010) was treat-
ed with antibiotics and urinary acidification. After re-
ferral, a prostatectomy was performed and amoxicillin 
15 mg/kg every 48h was given for 7 days postopera-
tively. Two years after the surgery, this animal was 
not showing any problems related to recurrence of the 
disease or metastasis. This is currently the only case 
where it seems possible that the animal was cured.
The treatment of the Siberian cat in Lapshin and 
Kondratova’s article (Lapshin and Kondratova, 2015) 
was aimed to alleviate symptoms. It was euthanized 
when the owner was unable to continue therapy. 
Whether or not metastasis was present, was not spec-
ified.
The first cat in the text of Villalobos and Kaplan 
(Villalobos and Kaplan, 2017) underwent debulking 
surgery and open cystotomy. Afterwards, it received 
mitoxantrone and piroxicam for recurrent disease. The 
animal survived for one year. The presence of metas-
tases was not discussed. The second cat was treated 
with mitoxantrone every 21 days and piroxicam 1 mg 
daily After six of these cycles, carboplatin was initiat-
ed. The cat lived for one more year and presented with 
cutaneous metastases in the last six months.
The cat in the case report of Oliveira (Oliveira et 
al., 2019) underwent a laparotomy for tumour exci-
sion. Because of the involvement of the urethra, a 
urethral anastomosis was performed to allow for a 
continued urine flow. Four hours after surgery, the 
animal died. The authors state that the death was not 
related to complications related to the surgical proce-
dure. There was no sign of pulmonary metastasis in 
this animal.
Due to the lack of research investigating a causal 
relationship between treatment strategies and survival 
outcome, no definitive conclusions can be made re-
garding the effectiveness of the different treatments. 
Both the use of surgery, mainly prostatectomy and 
chemotherapy have been described. Currently there 
has only been a single case where the animal was 
alive at the time of the publication of the article. In all 
other cases, the animal died within a year, often due 
to euthanasia. Metastasis was often identified at the 
time of necropsy, usually to the lungs, but metastasis 
to other regions such as the pancreas and myocardium 
was also described. Some animals were also free of 
metastasis. On several occasions, there was infiltra-
tion of mediastinal lymph nodes.
FUTURE RESEARCH
The currently literature regarding feline prostatic 
neoplasms is very limited and suffers from a lack of 
internal validity. This precludes any conclusion re-
garding the general effectiveness of a specific treat-
ment strategy. A first step in improving the knowledge 
of this condition is to collect information about cases 
of feline prostate cancer in a more systematic way. A 
larger collection of case reports and case series could 
provide better information about the epidemiology of 
the disease and current treatment practices.
In parallel, a multi-institutional retrospective study 
could also provide more insight into the epidemiolo-
gy of the condition but could also investigate associ-
ations between treatment strategies utilized for feline 
prostatic neoplasms and survival outcomes. With a 
large retrospective study, the associations between the 
utilization of treatment strategies and post-treatment 
complications could be investigated. For example, it 
could be interesting to assess the association between 
prostatectomy and post-operative urinary inconti-
nence in feline prostatic cancer patients. 
Based on the current, limited evidence for any 
treatment strategy, it may not be justified to perform 
a prospective clinical trial at this point. It is current-
ly not clear what treatment strategy should be tested 
in such a trial. Furthermore, due to the very limited 
incidence of the condition, a clinical trial may not be 
feasible due to the difficult of reaching a sufficient 
sample size. 
CONCLUSION
The literature regarding feline prostate cancer is 
very sparse and consists mainly of single case reports. 
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This makes it difficult to make sound conclusions 
about the epidemiology and the effectiveness of the 
treatments strategies that are utilized. The literature 
suggests that the condition mainly affects older cats 
and that these tumours are usually (adeno)carcinomas. 
Feline prostatic cancer patients often suffer from hae-
maturia, dysuria and inappetence. The current treat-
ment strategies, surgery and/or chemotherapy, often 
fail to cure the condition. Further research is needed 
to establish causal links between treatments strategies 
and survival outcomes.
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